The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
Open accessAbstract
Hepatitis B virus (HBV) infection is one of the most frequent causes of chronic liver disease worldwide. Because recent studies have suggested that Toll-like receptor (TLR)-based therapies may be a promising approach in the treatment of HBV infection, we studied the role of the local innate immune system of the liver as a possible mediator of this effect. Murine nonparenchymal cells, including Kupffer cells (KCs) and sinusoidal endothelial cells (LSECs), were isolated from C57/BL6 wild-type or MyD88−/− mice and stimulated by agonists of TLR1 to TLR9. Supernatants were harvested and assayed for their antiviral activity against HBV in HBV-Met cells. No direct antiviral effect of TLR agonists could be observed. In controls (myeloid dendritic cells), TLR1, TLR3, TLR4, TLR7, and TLR9 activation lead to production of antiviral cytokines. By contrast, only supernatants from TLR3-stimulated and TLR4-stimulated KCs and TLR3-stimulated LSECs from wild-type mice were able to potently suppress HBV replication as assessed via Southern blotting. Similar results were found with cells from MyD88−/− mice, indicating that the effect was independent of this signaling pathway. Cellular HBV RNA and hepatitis B surface antigen or hepatitis B e antigen levels in supernatants remained unchanged. Using neutralizing antibodies, we demonstrated that the TLR3-mediated effect but not the TLR4-mediated effect is mediated exclusively through interferon-β. Conclusion: Our data indicate that the innate immune system of the liver can control HBV replication after activation by TLR agonists. This has implications for the development of TLR-based therapeutic approaches against HBV. (Hepatology 2007.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., & Steinman, R. M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1693 · Cited by 3,738
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., et al. (2003) · Nature · doi:10.1038/nature01889 · Cited by 1,231
LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF
Fitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., Monks, B., Pitha, P. M., & Golenbock, D. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031023 · Cited by 1,193
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Toll-like receptor function and signaling
Kaisho, T., & Akira, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.023 · Cited by 898
Endotoxin signal transduction in macrophages
Sweet, M. J., & Hume, D. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.8 · Cited by 793
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
High-level hepatitis B virus replication in transgenic mice
Guidotti, L. G., Matzke, B., Schaller, H., & Chisari, F. V. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6158-6169.1995 · Cited by 642
Local control of the immune response in the liver
Knolle, P. A., & Gerken, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017408.x · Cited by 603
Self-citationChronic hepatitis B: Update of recommendations† ‡
Lok, A. S. F., & McMahon, B. J. (2004) · Hepatology · doi:10.1002/hep.20110 · Cited by 500
Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo
Isogawa, M., Robek, M. D., Furuichi, Y., & Chisari, F. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.7269-7272.2005 · Cited by 442
Toll-Like Receptor Signaling in the Liver
Schwabe, R. F., Seki, E., & Brenner, D. A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.038 · Cited by 401
Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge
Knoll, P., Schlaak, J., Uhrig, A., Kempf, P., zum Büschenfelde, K.-H. M., & Gerken, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80433-1 · Cited by 384
Self-citationRegulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Visvanathan, K., Skinner, N. A., Thompson, A. J. V., Riordan, S. M., Sozzi, V., Edwards, R., Rodgers, S., Kurtovic, J., Chang, J., Lewin, S., et al. (2007) · Hepatology · doi:10.1002/hep.21482 · Cited by 339
McClary, H., Koch, R., Chisari, F. V., & Guidotti, L. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2255-2264.2000 · Cited by 255
Wieland, S. F., Guidotti, L. G., & Chisari, F. V. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4165-4173.2000 · Cited by 243
Maier, H., Isogawa, M., Freeman, G. J., & Chisari, F. V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2714 · Cited by 232
Activation of anti-hepatitis C virus responses via Toll-like receptor 7
Lee, J., Wu, C. C. N., Lee, K. J., Chuang, T.-H., Katakura, K., Liu, Y.-T., Chan, M., Tawatao, R., Chung, M., Shen, C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510801103 · Cited by 211
Feng, C. G., Scanga, C. A., Collazo-Custodio, C. M., Cheever, A. W., Hieny, S., Caspar, P., & Sher, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4758 · Cited by 198
Dynamics of hepatitis B virus clearance in chimpanzees
Murray, J. M., Wieland, S. F., Purcell, R. H., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508913102 · Cited by 166
Adaptor usage and Toll‐like receptor signaling specificity
Dunne, A., & O'Neill, L. A. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.024 · Cited by 156
Noncytopathic Clearance of Lymphocytic Choriomeningitis Virus from the Hepatocyte
Guidotti, L. G., Borrow, P., Brown, A., McClary, H., Koch, R. J., & Chisari, F. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1555 · Cited by 147
MyD88 as a Bottle Neck in Toll/IL-1 Signaling
Takeuchi, O., & Akira, S. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_10 · Cited by 140
Breiner, K. M., Schaller, H., & Knolle, P. (2001) · Hepatology · doi:10.1053/jhep.2001.27810 · Cited by 134
[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines].
Lok, A. S.-F., & McMahon, B. J. (2004) · PubMed · Cited by 132
Cytokine-Sensitive Replication of Hepatitis B Virus in Immortalized Mouse Hepatocyte Cultures
Pasquetto, V., Wieland, S. F., Uprichard, S. L., Tripodi, M., & Chisari, F. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5646-5653.2002 · Cited by 126
Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice
Guidotti, L. G., McClary, H., Loudis, J. M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1247 · Cited by 120
Kimura, K., Kakimi, K., Wieland, S. F., Guidotti, L. G., & Chisari, F. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5188 · Cited by 114
Cheng, J., Imanishi, H., Morisaki, H., Liu, W., Nakamura, H., Morisaki, T., & Hada, T. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.033 · Cited by 69
Host–Virus Interactions during Malaria Infection in Hepatitis B Virus Transgenic Mice
Pasquetto, V., Guidotti, L. G., Kakimi, K., Tsuji, M., & Chisari, F. V. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.529 · Cited by 69
Tang, T., Kwekkeboom, J., Laman, J. D., Niesters, H. G. M., Zondervan, P. E., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00412.x · Cited by 67
Effect of Nitric Oxide on Poliovirus Infection of Two Human Cell Lines
López‐Guerrero, J. A., & Carrasco, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2538-2540.1998 · Cited by 32
Klöcker, U., Schultz, U., Schaller, H., & Protzer, U. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5525-5533.2000 · Cited by 28
Cited by
Toll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Toll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Control of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552
“A growing body of evidence indicates that several viruses evolved mechanisms to directly suppress the host defence by altering different pathways of the innate immune response [57,58].”
BackgroundRole of liver sinusoidal endothelial cells in liver diseases
Gracia-Sancho, J., Caparrós, E., Fernández-Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 410
Metadata
- Authors
- Wu, J., Lu, M., Meng, Z., Trippler, M., Broering, R., Szczeponek, A., Krux, F., Dittmer, U., Roggendorf, M., Gerken, G., & Schlaak, J. F.
- Venue
- Hepatology
- Published
- 2007-12
- Volume
- 46
- Issue
- 6
- Pages
- 1769-1778
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1982531307
- Cited by
- 274
- References
- 39
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.